Trial Profile
Novel oral MS treatments: one-year real-life experience with 128 patients treated with dimethyl-fumarate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 20 Feb 2016 New trial record